ArticleBuilding and environment2023
Large-scale evaluation of microorganism inactivation by bipolar ionization and photocatalytic devices.
Article in Building and environment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 32 citations in OpenAlex.
- Elimination of Airborne Microorganisms Using Compressive Heating Air Sterilization Technology (CHAST): Laboratory and Nursing Home Setting.Microorganisms · 2025Article
- Needle point bipolar ionization: environmental safety and inactivation of airborne bacteria and corona virus.Environmental science and pollution research international · 2025Article
- Factors Affecting Reduction of Infectious Aerosols by Far-UVC and Portable HEPA Air Cleaners.ACS ES&T air · 2025Article
- Bipolar Ionization Did Not Reduce Airborne Bacteria in a Lecture Hall.ACS ES&T air · 2024Article
- Hospital-borne hazardous air pollutants and air cleaning strategies amid the surge of SARS-CoV-2 new variants.Heliyon · 2024Review
- Reducing Transmission of Airborne Respiratory Pathogens: A New Beginning as the COVID-19 Emergency Ends.Environmental health perspectives · 2024Review
- Impact of test methodology on the efficacy of triethylene glycol (Grignard Pure) against bacteriophage MS2.Aerosol science and technology : the journal of the American Association for Aerosol Research · 2023Article
- Efficient deactivation of aerosolized pathogens using a dielectric barrier discharge based cold-plasma detergent in environment device for good indoor air quality.Scientific reports · 2023Article
- Direct and indirect healthcare and carbon savings with ACTIVE Particle ControlFrontiers in public health · 2022Article
- Filling Critical Science Gaps: EPA Office of Research and Development's Response to COVID-19.EM plusArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has raised awareness in the spread of disease via airborne transmission. As a result, there has been increasing interest in technologies that claim to reduce concentrations of airborne pathogens in indoor environments. The efficacy of many of these emerging technologies is not fully understood, and the testing that has been done is often conducted at a small scale and not representative of applied settings. There is currently no standard test method for evaluating air treatment technologies, making it difficult to compare results across studies or technology types. Here, a consistent testing approach in an operational-scale test chamber with a mock recirculating heating, ventilation, and air conditioning (HVAC) system was used to evaluate the efficacy of bipolar ionization and photocatalytic devices against the non-enveloped bacteriophage MS2 in the air and on surfaces. Statistically significant differences between replicate sets of technology tests and control tests (without technologies active) are apparent after 1 h, ranging to a maximum of 0.88 log
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.